HomeENLV • NASDAQ
Follow
Enlivex Therapeutics Ltd
Previous close
$1.45
Day range
$1.40 - $1.56
Year range
$1.15 - $4.59
Market cap
27.53M USD
Avg Volume
271.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.09M | -22.36% |
Net income | -9.10M | -26.51% |
Net profit margin | — | — |
Earnings per share | -0.48 | -23.08% |
EBITDA | -5.89M | 22.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 27.32M | -45.63% |
Total assets | 36.83M | -45.55% |
Total liabilities | 6.75M | -37.53% |
Total equity | 30.08M | — |
Shares outstanding | 18.60M | — |
Price to book | 0.90 | — |
Return on assets | -36.36% | — |
Return on capital | -40.93% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.10M | -26.51% |
Cash from operations | -5.28M | -9.53% |
Cash from investing | 4.14M | 243.78% |
Cash from financing | 0.00 | — |
Net change in cash | -1.14M | 85.16% |
Free cash flow | -6.24M | -26.22% |
About
Founded
Jan 22, 2012
Employees
77